Evidence map›Paper›PMID 27025297›Full record

Trial reportThe journal of allergy and clinical immunology. In practice

Individualized Household Allergen Intervention Lowers Allergen Level But Not Asthma Medication Use: A Randomized Controlled Trial.

Emily DiMango, Denise Serebrisky, Surinder Narula, Chang Shim, Claire Keating, Beverly Sheares, Matthew Perzanowski, Rachel Miller, Angela DiMango, Howard Andrews and 4 more

Open access · greenAbstract readRandomized Controlled Trial
In one paragraph

Trial report in The journal of allergy and clinical immunology. In practice. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed
7.0field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 71 citations in OpenAlex.

  1. Trial
  2. Patterns and predictors of air purifier adherence in children with asthma living in low-income, urban households.The Journal of asthma : official journal of the Association for the Care of Asthma · 2022
    Trial
  3. Trial
  4. Trial
  5. Trial
  6. Trial
  7. Effective pest control alone reduces mouse allergens in low-income housing.The journal of allergy and clinical immunology. Global · 2025
    Article
  8. Indoor Allergen Interventions in Homes and Schools for Managing Asthma.The journal of allergy and clinical immunology. In practice · 2025
    Review
  9. Review
  10. The Impact of the Indoor Environment on Childhood Asthma.Current allergy and asthma reports · 2025
    Review
  11. Minimizing Indoor Allergen Exposure: What Works?Current allergy and asthma reports · 2024
    Review
  12. Impact of socioeconomic factors on allergic diseases.The Journal of allergy and clinical immunology · 2024
    Review
  13. Article
  14. Indoor Environmental Exposures and Their Relationship to Allergic Diseases.The journal of allergy and clinical immunology. In practice · 2023
    Article
  15. Review
  16. Environmental Exposures Impact Pediatric Asthma Within the School Environment.Immunology and allergy clinics of North America · 2022
    Review
  17. Update on indoor allergens and their impact on pediatric asthma.Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology · 2022
    Review
  18. The influence of urban exposures and residence on childhood asthma.Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology · 2022
    Review
  19. Review
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors at 4 institutions in 1 country.

Emily DiMangoColumbia University Medical Center, New York, NY. Electronic address: ead3@columbia.edu.
Denise SerebriskyDepartments of Medicine and Pediatrics, Jacobi Medical Center, Bronx, NY.
Surinder NarulaColumbia University Medical Center, New York, NY.
Chang ShimDepartments of Medicine and Pediatrics, Jacobi Medical Center, Bronx, NY.
Claire KeatingColumbia University Medical Center, New York, NY.
Beverly ShearesColumbia University Medical Center, New York, NY.
Matthew PerzanowskiDepartment of Environmental Health Sciences, Mailman School of Public Health, Columbia University, New York, NY.
Rachel MillerColumbia University Medical Center, New York, NY.
Angela DiMangoColumbia University Medical Center, New York, NY.
Howard AndrewsDepartment of Biostatistics, Mailman School of Public Health, Columbia University, New York, NY.
David MerleDepartment of Biostatistics, Mailman School of Public Health, Columbia University, New York, NY.
Xinhua LiuDepartment of Biostatistics, Mailman School of Public Health, Columbia University, New York, NY.
Agustin CalatroniRho Federal Systems Division, Chapel Hill, NC.
Meyer KattanColumbia University Medical Center, New York, NY.
Columbia University Irving Medical Center · USColumbia University · USJacobi Medical Center · USRho (United States) · US

Funding

True Metal fac coreP30ES009089 · NIEHS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI MATTHEW S PERZANOWSKI · 1998 to 2026
$44.7M
NIEHS NIH HHS P30 ES009089
6 · The paper itself

Abstract

backgroundEnvironmental exposures to indoor allergens are major contributors to asthma symptoms, particularly in inner cities. The effectiveness of household allergen reduction as an adjunct to National Asthma Education Prevention Program guideline-based pharmacologic therapy in asthma has not been prospectively studied.

objectiveTo study the effect of individualized allergen reduction on ability to reduce asthma pharmacologic therapy over 40 weeks.

methodsWe performed a randomized controlled trial to determine the effect of multifaceted indoor allergen avoidance measures on the ability to reduce asthma controller therapy in adults and children residing in New York City who were both sensitized and exposed to at least 1 indoor allergen. Asthma treatment and control were optimized in all subjects before randomization.

resultsA total of 125 subjects were randomized to receive individualized household allergen reduction and 122 received a sham intervention. Subjects in the intervention group significantly reduced all measured allergen levels (cat, dog, dust mite allergens in the bedroom, cockroach and mouse allergens in the kitchen and bedroom); those in the control group reduced only dust mite and mouse allergens in the bedroom and cockroach allergen in the kitchen. Participants in the intervention arm reduced National Asthma Education Prevention Program-based therapy from step 4.4 at randomization to 3.50 postintervention (range, 0-6); participants in the control arm reduced medication from step 4.4 to 3.4 (P = .76). There were no differences in other measured asthma outcomes.

conclusionsTargeted allergen avoidance measures do not allow for reduction in asthma pharmacologic therapy compared with usual care in patients already receiving optimal controller therapy.

Indexed as

AdolescentAdultAgedAllergensAnimalsAnti-Asthmatic AgentsAsthmaCatsChildCockroachesDogsEnvironmental ExposureFemaleForced Expiratory VolumeHousingHumansAllergensAnti-Asthmatic AgentsAllergensAsthmaAsthma controllerCockroachMouse

Identifiers

PMID27025297
PMCPMC5295498
OpenAlexW2310152440

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.